OSE Immunotherapeutics SA (EPA:OSE)
France
· Delayed Price · Currency is EUR 3.914
-0.104 (-2.59%)
At close: Mar 9, 2026
OSE Immunotherapeutics Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 90 | 115 | 157 | 81 | 123 | 188 | Upgrade
|
| Market Cap Growth | -37.97% | -26.38% | 94.71% | -34.73% | -34.26% | 45.49% | Upgrade
|
| Enterprise Value | 98 | 102 | 125 | 109 | 128 | 184 | Upgrade
|
| Last Close Price | 4.02 | 5.15 | 7.17 | 4.28 | 6.67 | 10.28 | Upgrade
|
| PE Ratio | - | - | 4.19 | - | - | - | Upgrade
|
| Forward PE | - | 9.72 | 2.83 | - | - | - | Upgrade
|
| PS Ratio | 50.55 | 64.80 | 1.88 | 36.17 | 6.74 | 7.14 | Upgrade
|
| PB Ratio | 2.69 | 3.45 | 2.46 | 3.51 | 3.78 | 3.92 | Upgrade
|
| P/TBV Ratio | - | - | 2.46 | 3.53 | 3.80 | 3.93 | Upgrade
|
| P/FCF Ratio | - | - | 3.24 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 3.24 | - | - | - | Upgrade
|
| EV/Sales Ratio | 54.96 | 57.51 | 1.50 | 49.07 | 6.99 | 7.01 | Upgrade
|
| EV/EBITDA Ratio | - | - | 2.84 | - | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | 2.86 | - | - | - | Upgrade
|
| EV/FCF Ratio | -3.62 | - | 2.58 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.06 | 1.06 | 0.72 | 1.99 | 1.37 | 0.78 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 1.03 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 0.95 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.23 | 0.23 | -0.20 | 1.18 | 0.59 | 0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.27 | -0.27 | -0.29 | -1.34 | -1.22 | -0.24 | Upgrade
|
| Net Debt / FCF Ratio | -0.29 | -0.29 | -0.27 | -1.37 | -1.03 | -0.34 | Upgrade
|
| Asset Turnover | 0.02 | 0.02 | 0.81 | 0.03 | 0.19 | 0.27 | Upgrade
|
| Quick Ratio | 1.19 | 1.19 | 3.29 | 1.40 | 1.97 | 2.36 | Upgrade
|
| Current Ratio | 1.54 | 1.54 | 3.46 | 1.62 | 2.29 | 2.64 | Upgrade
|
| Return on Equity (ROE) | -66.82% | -66.82% | 86.29% | -82.69% | -44.10% | -30.85% | Upgrade
|
| Return on Assets (ROA) | -18.42% | -18.42% | 26.54% | -16.53% | -11.93% | -10.45% | Upgrade
|
| Return on Invested Capital (ROIC) | -66.55% | -66.55% | 81.47% | -45.10% | -35.78% | -32.30% | Upgrade
|
| Return on Capital Employed (ROCE) | -50.40% | -50.40% | 42.20% | -36.30% | -24.50% | -19.50% | Upgrade
|
| Earnings Yield | -36.10% | -28.16% | 23.88% | -28.56% | -14.39% | -8.98% | Upgrade
|
| FCF Yield | -30.03% | -23.43% | 30.84% | -24.56% | -15.01% | -5.54% | Upgrade
|
| Buyback Yield / Dilution | -3.76% | 14.22% | -31.11% | -5.58% | -2.05% | -16.71% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.